VRSN — VeriSign, Inc.

The market is bullish after Q2 2026 (reported July 23) revenue grew 6.0% YoY to $434.6M, EPS rose 7.7% to $2.38, and management raised full-year guidance; the stock reportedly jumped about 7% on the print. Wall Street consensus is Buy (9 buy, 5 hold, 1 sell), with price targets around $324-$355, and the .web gTLD delegation plus the .net price increase have added positive narrative. That said, the bullish tone sits against a rich 31.9x TTM multiple and notable insider selling.

The last three years show stable, slow-growth compounding, not cyclical turbulence. Revenue rose essentially every quarter from $376.3M (Sep-2023) to $434.6M (Jun-2026). YoY growth accelerated from roughly 3.9% (Dec-2024) to 7.6% (Dec-2025), then settled at 6.6% (Mar-2026) and 6.0% (Jun-2026). Gross margin expanded from 87.1% to 88.5%; operating margin has held in a tight 67%-69% band; net margin is around 50%, with the Dec-2023 spike to 69.6% driven by a one-off tax benefit. Trailing free cash flow is about $1.07B, and 2025 FCF was consistently stronger than 2024; Q2 is seasonally the lightest FCF quarter. This is a mature monopoly grinding out reliable growth, not an inflection point down.

As of 2026-08-27, VRSN is fairly valued versus its own history and expensive relative to its growth. TTM P/E is 31.9x; forward P/E on next-FY EPS of $9.79 is about 30.1x, close to the 5-year average P/E of 29.7x. P/S of 15.6x is essentially the 5-year average of 15.56x. PEG is 3.19 because EPS growth is roughly 10% and revenue growth only about 6%, so this is not a growth-at-a-reasonable-price story. The 1.17% dividend yield and roughly 4.0% FCF yield give some support, but the stock is not cheap.

The price has already run ahead of what the historical multiple would justify: applying the 5-year average P/E of 29.7x to forward EPS of $9.79 gives about $290.8, essentially the current $294.73 price. The consensus target of $339.5 implies roughly 34.7x forward EPS, so bulls are assuming .web monetization, the .net price increase, and continued buybacks add meaningfully to growth. If those land, estimates go up; if domain growth stalls, the multiple is more likely to compress toward 28-30x than expand. This is a steady-compounder trade, not a beaten-down turnaround.

As of 2026-08-27, RSI stood at 59.7, positive but not overbought. Price was 2.38% above its 20-day SMA, 7.3% above its 50-day SMA, and 13.13% above its 200-day SMA, so the trend is clearly up. Chasing after a 13% gain above the 200-day gives below-average entry timing; a pullback toward the 50-day or the $285-$290 zone would offer better risk/reward, but momentum is not yet overextended.

• ICANN regulatory framework: VeriSign's .com/.net pricing is contractually capped; the announced .net fee increase from $10.91 to $12.00, effective March 1, 2027, is a concrete regulation-driven revenue driver.
• Interest-rate environment: VRSN's long-duration, subscription-like cash flows make it a defensive bond-proxy equity; moderate rates support its ~30x multiple, while sharply higher rates would pressure it.
• Domain-industry cycle: .com/.net registrations rose 5.1% YoY to 179.1M, tied to business formation and renewal rates; steady but low-growth, with limited cyclical kick.
• Capital-return mechanics: debt-funded buybacks have driven stockholders' equity to -$2.25B; the 0.59 current ratio and 1.17% dividend yield make this more a cash-return vehicle than a balance-sheet fortress.

• Q3 2026 earnings, expected late October 2026, for an update on renewal rates, full-year guidance, and buyback pace.
• Commercial rollout of .web gTLD later in 2026, adding a new registrar-channel revenue stream.
• .net wholesale price increase to $12.00 from $10.91 effective March 1, 2027, a direct 2027 revenue and EPS tailwind.
• Continued share repurchases under the remaining $1.50B authorization, plus the quarterly $0.81/share dividend.

• Regulatory/political pricing risk: ICANN terms and government oversight could limit future .com/.net price increases, removing the main organic growth lever.
• Volume/renewal deceleration: if the 179.1M domain base and 5.1% growth stall, revenue growth could fall toward 3-4%, making 32x earnings hard to justify.
• Balance-sheet/leverage: negative equity (-$2.25B) and $1.79B long-term debt mean the company is optimized for debt-funded buybacks; a cash-flow shock or sharply higher rates would reduce flexibility.
• Valuation multiple compression: at roughly 30x forward earnings for ~6% revenue growth, any shift away from safe/bond-proxy sentiment could compress the P/E.
• Insider selling, including CEO/insider sales over the past 12 months, is a modest governance overhang.

VRSN is an elite tollbooth: a regulated monopoly, 88.5% gross margin, ~68% operating margin, and reliable free cash flow. But at $294.73, the market already pays a premium for that safety, so the expected return is mostly limited to dividend, buyback, and mid-single-digit organic growth, with modest upside to my ~$314 fair value. It is a reasonable hold or buy-on-pullback, not a compelling new-money buy; overall neutral.

Calculated by capitalizing trailing FCF per share of about $11.79 (TTM FCF of $1,066.1M divided by roughly 90.4M shares) at a 3.75% justified FCF yield, a slight premium to the market-implied ~4.0% yield due to VeriSign's regulatory moat and cash-flow stability; cross-checking with roughly 32x forward EPS of $9.79 gives a similar $314 figure.